CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-17 | ROBINS CHAD M CEO and Chairman | Sale | −400 | $43.76 | $18K | 1,806,220 |
| 2020-06-17 | ROBINS CHAD M CEO and Chairman | Sale | −28,040 | $44.38 | $1.2M | 1,778,180 |
| 2020-06-17 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −28,440 | 423,120 | ||
| 2020-06-15 | HERSHBERG ROBERT Director | Option exercise | +2,000 | $0.45 | $900 | 2,000 |
| 2020-06-15 | HERSHBERG ROBERT Director | Sale | −1,016 | $42.59 | $43K | 984 |
| 2020-06-15 | HERSHBERG ROBERT Director | Sale | −984 | $43.42 | $43K | 0 |
| 2020-06-15 | HERSHBERG ROBERT Director | Option exercise · Stock Option (Right to Buy) | −2,000 | 71,000 | ||
| 2020-06-09 | BALDO LANCE Chief Medical Officer | Option exercise | +4,167 | $7.80 | $33K | 4,167 |
| 2020-06-09 | BALDO LANCE Chief Medical Officer | Sale | −4,167 | $40.00 | $167K | 0 |
| 2020-06-09 | BALDO LANCE Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,167 | 443,750 | ||
| 2020-06-09 | Cohen Chad M Chief Financial Officer | Option exercise | +8,750 | $6.32 | $55K | 9,750 |
| 2020-06-09 | Cohen Chad M Chief Financial Officer | Sale | −8,750 | $40.00 | $350K | 1,000 |
| 2020-06-09 | Cohen Chad M Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −8,750 | 670,000 | ||
| 2020-06-08 | BALDO LANCE Chief Medical Officer | Option exercise | +2,083 | $7.80 | $16K | 2,083 |
| 2020-06-08 | BALDO LANCE Chief Medical Officer | Sale | −120 | $39.59 | $5K | 1,963 |
| 2020-06-08 | BALDO LANCE Chief Medical Officer | Sale | −1,963 | $38.99 | $77K | 0 |
| 2020-06-08 | BALDO LANCE Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −2,083 | 447,917 | ||
| 2020-06-08 | Cohen Chad M Chief Financial Officer | Option exercise | +21,250 | $6.32 | $134K | 22,250 |
| 2020-06-08 | Cohen Chad M Chief Financial Officer | Sale | −18,805 | $38.99 | $733K | 3,445 |
| 2020-06-08 | Cohen Chad M Chief Financial Officer | Sale | −2,445 | $39.80 | $97K | 1,000 |
Page 102 of 120 · 2,386 trades